DKK1 and Wilms tumor: However, overexpression of DKK1 has been observed in various malignant tumors and is also correlated with adverse prognosis in patients with multiple myeloma, hepatoblastoma, Wilm’s tumor, lung cancer, and breast cancer [19–22].